Form 4: UnitedHealth Group Director McNabb Acquires Shares as Part of Compensation

Director Frederick William McNabb III acquired 164 shares of UnitedHealth Group common stock as part of his quarterly compensation.

Summary

• On October 1, 2024, Frederick William McNabb III, a director of UnitedHealth Group, acquired 164 shares of common stock.
• The acquisition was part of his regular quarterly compensation for serving as a director.
• The shares were acquired at a price of $0, indicating they were granted as deferred stock units.
• Following the transaction, McNabb directly owns 13,223 shares of UnitedHealth Group common stock.
• These deferred stock units are immediately vested but must be retained until McNabb completes his service on the Board.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating stability and alignment of interests. It's a neutral to slightly positive signal.

Positives

• The acquisition of shares by a director demonstrates alignment with shareholder interests.
• The structure of deferred stock units incentivizes long-term commitment to the company.

Future Outlook

The document does not contain specific forward-looking statements, but the ongoing compensation structure suggests continued alignment of director interests with the company's performance.

Industry Context

Director compensation in the form of stock is a common practice in publicly traded companies to align the interests of management and shareholders. This filing reflects standard compensation practices within the healthcare industry.

Comparison to Industry Standards

• Granting stock options or restricted stock units to directors is a common practice among S&P 500 companies, including UnitedHealth Group's peers like CVS Health, Anthem (Elevance Health), and Cigna.
• The vesting schedules and holding requirements for these equity grants often vary, but the general principle is to incentivize long-term value creation.
• The specific number of shares granted and the valuation methods used are typically disclosed in the company's proxy statements.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders by aligning the director's interests with the company's long-term performance.
• The compensation structure reinforces the director's commitment to the company.

Key Dates